ArticleClinical colorectal cancer2018

Gene Polymorphisms in the CCL5/CCR5 Pathway as a Genetic Biomarker for Outcome and Hand-Foot Skin Reaction in Metastatic Colorectal Cancer Patients Treated With Regorafenib.

Mitsukuni Suenaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.